PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.\', \'Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America.\', \'Section of Hematology, Yale School of Medicine, New Haven, Connecticut, United States of America.\', \'VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.\', \'Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, United States of America.\', \'Pfizer, Inc., New York, New York, United States of America.\', \'Section of Allergy and Clinical Immunology, Yale School of Medicine, New Haven, Connecticut, United States of America.\', \'Section of Pulmonology and Critical Care Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.\', \'Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.\', \'Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pbio.3001373
?:doi
?:hasPublicationType
?:journal
  • PLoS biology
is ?:pmid of
?:pmid
?:pmid
  • 34358229
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.941
?:rankingScore_hIndex
  • 214
?:title
  • Challenges in interpreting cytokine data in COVID-19 affect patient care and management.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all